Cellectar Biosciences, Inc.
CLRB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001279704
No open-market purchases or sales by Cellectar Biosciences, Inc. insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $9.08M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Cellectar Biosciences, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 30
- −4 vs. Q3 2024
- Shares held
- 5.10M
- −8.88M (−63.5%) vs. Q3 2024
- Total value
- $1.52M
- −$28.4M (−94.9%) vs. Q3 2024
- New holders
- 6
- 11 more added
- Sold out
- 10
- 5 more reduced
1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CLRB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 29 | $9.08M |
| Q1 2026 | 19 | $812.9K |
| Q4 2025 | 20 | $1.04M |
| Q3 2025 | 21 | $1.65M |
| Q2 2025 | 19 | $734.0K |
| Q1 2025 | 32 | $1.63M |
| Q4 2024 | 30 | $1.52M |
| Q3 2024 | 35 | $30.0M |
| Q2 2024 | 37 | $28.3M |
| Q1 2024 | 45 | $36.3M |
| Q4 2023 | 26 | $23.9M |
| Q3 2023 | 20 | $3.85M |
| Q2 2023 | 21 | $3.08M |
| Q1 2023 | 21 | $2.43M |
| Q4 2022 | 26 | $3.22M |
| Q3 2022 | 22 | $2.14M |
| Q2 2022 | 33 | $3.61M |
| Q1 2022 | 32 | $4.69M |
| Q4 2021 | 42 | $4.38M |
| Q3 2021 | 40 | $6.77M |
| Q2 2021 | 46 | $14.9M |
| Q1 2021 | 45 | $24.2M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Cellectar Biosciences, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| AllSquare Wealth Management LLC | 18 | $5 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 40 | $12 | 0.00% | 00.0% | Unchanged |
| EnRich Financial Partners LLC | 102 | $30 | 0.00% | 00.0% | Unchanged |
| US Bancorp | 385 | $115 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 400 | $120 | 0.00% | +400 | New |
| Citigroup Inc | 660 | $197 | 0.00% | +660 | New |
| BFSG, LLC | 1,000 | $299 | 0.00% | 00.0% | Unchanged |
| Group One Trading, L.P. | 1,398 | $418 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 2,721 | $816 | 0.00% | −125−4.4% | Reduced |
| Oppenheimer & Co Inc | 12,500 | $3.74K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 12,051 | $4.00K | 0.00% | +12,051 | New |
| Sequoia Financial Advisors, LLC | 14,500 | $4.34K | 0.00% | −9,300−39.1% | Reduced |
| BNP Paribas Arbitrage, SA | 16,815 | $5.03K | 0.00% | +16,815 | New |
| Simplex Trading, LLC | 40,743 | $12.0K | 0.00% | +40,318+9,486.6% | Added |
| Goldman Sachs Group Inc | 42,462 | $12.7K | 0.00% | +21,937+106.9% | Added |
| XTX Topco Ltd | 46,876 | $14.0K | 0.00% | −6,146−11.6% | Reduced |
| Two Sigma Securities, LLC | 51,952 | $15.5K | 0.00% | +29,153+127.9% | Added |
| Two Sigma Investments, LP | 71,119 | $21.3K | 0.00% | +71,119 | New |
| Northern Trust Corp | 77,988 | $23.3K | 0.00% | +16,894+27.7% | Added |
| State Street Corp | 128,114 | $38.3K | 0.00% | +11,300+9.7% | Added |
| Morgan Stanley | 178,719 | $53.4K | 0.00% | +39,488+28.4% | Added |
| JPMorgan Chase & Co | 182,403 | $54.5K | 0.00% | +159,234+687.3% | Added |
| Bank of America Corp | 206,783 | $61.8K | 0.00% | +41,704+25.3% | Added |
| Altium Capital Management LP | 215,000 | $64.3K | 0.02% | 00.0% | Unchanged |
| BlackRock, Inc. | 232,509 | $69.5K | 0.00% | +189+0.1% | Added |
| Geode Capital Management, LLC | 350,885 | $104.9K | 0.00% | −1,567−0.4% | Reduced |
| UBS Group AG | 376,199 | $112.5K | 0.00% | +373,622+14,498.3% | Added |
| Squarepoint Ops LLC | 520,240 | $155.6K | 0.00% | +520,240 | New |
| ADAR1 Capital Management, LLC | 585,261 | $175.0K | 0.04% | −436,900−42.7% | Reduced |
| Vanguard Group Inc | 1,727,001 | $516.4K | 0.00% | +150.0% | Added |
| Rosalind Advisors, Inc. | 0 | $0 | 0.00% | −3,671,550−100.0% | Sold out |
| AIGH Capital Management LLC | 0 | $0 | 0.00% | −3,197,394−100.0% | Sold out |
| Nantahala Capital Management, LLC | 0 | $0 | 0.00% | −2,712,443−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −120,497−100.0% | Sold out |
| Pale Fire Capital SE | 0 | $0 | 0.00% | −25,030−100.0% | Sold out |
| Integrated Wealth Concepts LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −16,134−100.0% | Sold out |
| Commerce Bank | 0 | $0 | 0.00% | −14,000−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −2,285−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −303−100.0% | Sold out |
| Raymond James Financial Services Advisors, Inc. | – | – | – | – | Not filed |